Welcome to our dedicated page for Ainos SEC filings (Ticker: AIMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ainos, Inc. (NASDAQ: AIMD) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Texas corporation with shares listed on the Nasdaq Stock Market, Ainos submits periodic reports, proxy statements, and current reports that document its financial condition, governance decisions, and material agreements.
For investors tracking Ainos’ transition into an AI-powered digital olfaction and SmellTech company, Form 10-K annual reports and Form 10-Q quarterly reports are key sources for detailed discussions of the AI Nose platform, Smell Language Model (SLM), VELDONA oral interferon program, research and development spending, and risk factors. Form 8-K current reports capture material events such as financial result announcements, entry into or amendments of product development agreements, and other significant corporate actions.
Ainos’ DEF 14A proxy statements provide insight into board elections, auditor ratification, stock award proposals, and shareholder voting outcomes, reflecting how the company structures its governance and equity incentives. Filings also identify Ainos’ state of incorporation, trading symbols (AIMD for common stock and AIMDW for warrants), and other corporate details.
On Stock Titan, these filings are complemented by AI-powered summaries that highlight the most important points from lengthy documents, helping users quickly understand changes in capital structure, major contracts, or strategic direction without reading every page. Real-time updates from EDGAR ensure that new Ainos filings, including Forms 4 reporting insider transactions when available, appear promptly, while AI-generated overviews of 10-Ks and 10-Qs make complex disclosures more accessible to both experienced and newer investors.
Ainos, Inc. (AIMD) reported a Form 4 showing that Taiwan Carbon Nano Technology Corporation, a director-related reporting person, sold 2,000 shares of common stock on
Taiwan Carbon Nano Technology Corporation, identified as a director of Ainos, Inc. (AIMD), reported two open-market stock sales. On 09/30/2025 the reporting person sold 1,006 shares at $3.5167 each, reducing beneficial holdings to 1,047,906 shares. On 10/01/2025 they sold 1,700 shares at $3.4633, reducing holdings to 1,046,206 shares. The filing states the shares were sold for general operating purposes. The transactions are reported as direct beneficial ownership and coded as sales.
Ainos, Inc. provides details in its definitive proxy about ownership, director compensation and executive pay adjustments. Two large shareholders are disclosed: Taiwan Carbon Nano Technology Corporation holds 5,500,000 shares (35.64%) and ASE Test, Inc. holds 2,312,077 shares (13.05%). The document discloses board compensation rates including an annual chair retainer of $14,000, audit chair $7,000, compensation chair $4,500, audit committee members $4,000, and compensation committee members $3,000. Director ages are listed (examples: Wen-Han Chang 62; Yao-Chung Chiang 73; Pao-Sheng Wei 67). Chun-Hsien Tsai served as CEO and received a 2023 base salary of $122,517, bonus $115,313 and stock awards valued at $63,692. The proxy includes adjustments used to calculate "compensation actually paid" and reports total compensation actually paid figures (examples: $209,991, $440,794, $223,625, $551,615). The board will solicit proxies to ratify YCM as the independent registered public accounting firm for fiscal 2024 and to authorize adjournment of the annual meeting.